Health-related quality of life and long-term survival and graft failure in kidney transplantation: A 12-year follow-up study

Transplantation

Volumn 95, Issue 5, 2013, Pages 740-749

  Griva, Konstadina ^a,b   Davenport, Andrew ^c   Newman, Stanton P ^b,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b CITY UNIVERSITY   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Graft failure; Kidney transplantation; Mortality; Quality of life

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHARLSON COMORBIDITY INDEX; COMORBIDITY; DEMOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; REOPERATION; RISK FACTOR; SOCIAL ASPECT; SURVIVAL; AGED; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

MLCS; MLOWN;

EID: 84877274116     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827d9772     Document Type: Article

References (59)

1. Lopes AA, Bragg-Gresham JL, Satayathum S, et al. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2003; 41: 605.
2. Jofre R, Lopez-Gomez JM, Moreno F, et al. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998; 32: 93.
3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
4. Tonelli M, Wiebe N, Knoll G, et al. Kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 2011; 11: 2093.
5. Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000; 35: 629.
6. Dew MA, Switzer GE, Goycoolea JM, et al. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation 1997; 64: 1261.
7. Dobbels F, De Bleser L, De Geest S, et al. Quality of life after kidney transplantation: the bright side of life? Adv Chronic Kidney Dis 2007; 14: 370.
8. Griva K, Ziegelmann JP, Thompson D, et al. Quality of life and emotional responses in cadaver and living related renal transplant recipients. Nephrol Dial Transplant 2002; 17: 2204.
9. Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64: 339.
10. Kalantar Zadeh K, Kopple JD, Block G, et al. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001; 12: 2797.
11. Knight EL, Ofsthun N, Teng M, et al. The association between mental health, physical function, and hemodialysis mortality. Kidney Int 2003; 63: 1843.
12. Lowrie EG, Curtin RB, LePain N, et al. Medical Outcomes Study Short-Form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 2003; 41: 1286.
13. Inouye SK, Peduzzi PN, Robison JT, et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998; 279: 1187.
14. Khouli H, Astua A, Dombrowski W, et al. Changes in health-related quality of life and factors predicting long-term outcomes in older adults admitted to intensive care units. Crit Care Med 2011; 39: 731.
15. Tsai SY, Chi LY, Lee Ch, et al. Health-related quality of life as a predictor of mortality among community-dwelling older persons. Eur J Epidemiol 2007; 22: 19.
16. Fan VS, Curtis JR, Tu SP, et al. Using quality of life to predict hos-pitalization and mortality in patients with obstructive lung diseases. Chest 2002; 122: 429.
17. Kleefstra N, Landman WD, Houweling ST, et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care 2008; 31: 932.
18. Rumsfeld JS, MaWhinney S, McCarthy M Jr, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. JAMA 1999; 281: 1298.
19. Schenkeveld L, Pedersen SS, van Nierop JW, et al. Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention. Am Heart J 2010; 159: 471.
20. Phillips AL, Walker EL, Martin JE, et al. Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant. Transplant Proc 2001; 33: 1886. (Pubitemid 32238104)
21. Molnar-Varga M, Molnar MZ, Szeifert L, et al. Health-related quality of life and clinical outcomes in kidney transplant recipients. Am J Kidney Dis 2011; 58: 444.
22. Greenfield S, Sullivan L, Silliman RA, et al. Principles and practice of case mix adjustment: applications to end-stage renal disease. Am J Kidney Dis 1997; 24: 298.
23. Kurtin P, Nissenson AR. Variation in end-stage renal disease patient outcomes: what we know, what should we know and how do we find it out? J Am Soc Nephrol 1993; 3: 1738.
24. Moore J, He XA, Liu XA, et al. Mortality prediction after kidney transplantation: comparative clinical use of 7 comorbidity indices. Exp Clin Transplant 2011; 9: 32.
25. Wu C, Evans I, Joseph R, et al. Comorbid conditions in kidney transplantation: an association with graft and patient survival. J Am Soc Nephrol 2005; 16: 3437.
26. U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
27. European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). Annual Report 2009. Amsterdam (The Netherlands): ERA-EDTA; 2011: 136p.
28. Pascual M, Theruvath T, Tatsuo K, et al. Medical progress: strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580.
29. Kahwaji J, Bunnapradist S, Hsu JW, et al. Cause of death with graft function among renal transplant recipients in an integrated healthcare system. Transplantation 2011; 91: 225.
30. Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant 2001; 16: 1545.
31. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84:985.
32. DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 1997; 30: 204.
33. Duffy JP, Kao K, Ko CY, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg 2010; 252: 652.
34. Novak M, Molnar MZ, Szeifert L, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 2010; 72: 527.
35. Fortin M, Hudon C, Dubois MF, et al. Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life. Health Qual Life Outcomes 2005; 23: 74.
36. Cohen HJ, Pieper CF, Harris T, et al. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 1997; 52: M201.
37. Christian LM, Glaser R, Porter K, et al. Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology 2011; 36: 1495.
38. Janszky I, Lekander M, Blom M, et al. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 2005; 19: 555.
39. Ross R. AtherosclerosisVan inflammatory disease. N Engl J Med 1999; 340: 115.
40. van Ree RM, Oterdoom LH, de Vries AP, et al. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients. Transplantation 2008; 86: 1713.
41. Malyszko J, Malyszko JS, Pawlak K, et al. Apelin, a novel adipocyto-kine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant Proc 2008; 40: 3466.
42. Abedini S, Meinitzer A, Holme I, et al. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int 2010; 77: 44.
43. Johnson JG, Gore SM, Firth J. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature. Nephrol Dial Transplant 1999; 14: 2156.
44. Chertow GM, Johansen KL, Lew N, et al. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 2000; 57: 1176.
45. Augustine JJ, Poggio ED, Clemente M, et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipient. J Am Soc Nephrol 2007; 18: 1602.
46. Webb L, Casula A, Ravanan R, et al. The Renal Association UK Renal Registry The Thirteenth Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2009: National and Centre-Specific Analyses. Bristol, England: UK Renal Registry; 2010: 32p.
47. Griva K, Hansraj S, Thompson D, et al. Neuropsychological performance after kidney transplantation: a comparison between transplant types and in relation to dialysis and normative data. Nephrol Dial Transplant 2004; 19: 1866.
48. World Health Organization (WHO). Body mass index (BMI) classification [Internet]. WHO; 2006 [updated 2012 January 3; cited 2012 January 3]. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro-3.html.
49. 51Cr/edetic-acid complex. Lancet 1967; 289: 818.
50. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373.
51. Jassal SV, Schaubel DE, Fenton SS. Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136.
52. Baskin-Bey ES, Kremers W, Nyberg SL. A recipient risk score for deceased donor renal allocation. Am J Kidney Dis 2007; 49: 284.
53. Karnofsky DA, Burcherval JH. The clinical evaluation of chemother-apeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemo-therapeutic Agents in Cancer. New York, NY: Columbia University Press; 1949: 191.
54. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute; 1993.
55. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. 4th printing, revised edition. Boston, MA: The Health Institute; 1994.
56. Jenkinson C, Layte R, Wright L, et al. The UK SF-36: An Analysis and Interpretation Manual. A Guide to Health Status Measurement with Particular Reference to the Short Form 36 Health Survey. Oxford: University of Oxford, Department of Public Health and Primary Care, Health Services Research Unit; 1996.
57. Edgell ET, Coons SJ, Carter WB, et al. A review of health-related quality-of-life measures used in end-stage renal disease. Clin Ther 1996; 18: 887.
58. Gomez-Besteiro MI, Santiago-Perez MI, Alonso-Hernández A, et al. Validity and reliability of the SF-36 questionnaire in patients on the waiting list for a kidney transplant and transplant patients. Am J Nephrol 2004; 24: 346.
59. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable university of half a standard deviation. Med Care 2003; 41: 582. College London Medical School